Healthcare
Stocks Ranked by
Market Capitalization
| # | Name | Market cap | Price |
Price change % |
|
|---|---|---|---|---|---|
| 1 |
1
Eli Lilly
LLY
$1.26T
| $1.26T | $1,417.54 | 3.19% |
|
| 2 |
2
Johnson & Johnson
JNJ
$658B
| $658B | $273.20 | 0.73% |
|
| 3 |
3
AbbVie
ABBV
$521B
| $521B | $294.89 | 1.41% |
|
| 4 |
4
Merck
MRK
$369B
| $369B | $149.52 | 2.18% |
|
| 5 |
5
UnitedHealth
UNH
$365B
| $365B | $406.97 | 0.96% |
|
| 6 |
6
Novartis
NVS
$304B
| $304B | $160.79 | 0.19% |
|
| 7 |
7
AstraZeneca
AZN
$289B
| $289B | $186.65 | 7.02% |
|
| 8 |
8
Thermo Fisher Scientific
TMO
$258B
| $258B | $697 | 1.72% |
|
| 9 |
9
Amgen
AMGN
$252B
| $252B | $466.01 | 1.15% |
|
| 10 |
10
Gilead Sciences
GILD
$212B
| $212B | $170.68 | 3.06% |
|
| 11 |
11
Abbott
ABT
$184B
| $184B | $106.20 | 1.56% |
|
| 12 |
12
Novo Nordisk
NVO
$176B
| $176B | $40 | 2.2% |
|
| 13 |
13
Pfizer
PFE
$174B
| $174B | $30.52 | 1.9% |
|
| 14 |
14
Danaher
DHR
$163B
| $163B | $232.23 | 2% |
|
| 15 |
15
Intuitive Surgical
ISRG
$153B
| $153B | $432.01 | 3.73% |
|
| 16 |
16
Vertex Pharmaceuticals
VRTX
$142B
| $142B | $558.88 | 3.5% |
|
| 17 |
17
Bristol-Myers Squibb
BMY
$128B
| $128B | $62.48 | 1.78% |
|
| 18 |
18
Medtronic
MDT
$123B
| $123B | $96.54 | 0.59% |
|
| 19 |
19
McKesson
MCK
$116B
| $116B | $994.58 | 1.4% |
|
| 20 |
20
CVS Health
CVS
$115B
| $115B | $90.25 | 0.09% |
|
| 21 |
21
Stryker
SYK
$112B
| $112B | $291.86 | 6.38% |
|
| 22 |
22
Sanofi
SNY
$106B
| $106B | $44.34 | 2.81% |
|
| 23 |
23
GSK
GSK
$99.2B
| $99.2B | $49.51 | 1.71% |
|
| 24 |
24
HCA Healthcare
HCA
$98.8B
| $98.8B | $473.19 | 1.02% |
|
| 25 |
25
Regeneron Pharmaceuticals
REGN
$96B
| $96B | $927.89 | 13.3% |
|
Healthcare Stocks at a Glance
Healthcare companies develop drugs, build medical devices, run hospitals and insurers, and supply the systems behind patient care. Demand is largely non-discretionary, but returns hinge on drug-pipeline outcomes, patent lives, and reimbursement policy — a mix of defensive services and high-risk, high-reward research bets.
There are 1,123 Healthcare sector stocks tracked by Wall St. Rank, worth a combined $10T.
The largest by market cap are Eli Lilly (LLY) at $1.26T, Johnson & Johnson (JNJ) at $658B and AbbVie (ABBV) at $521B.
Among institutional investors, UnitedHealth (UNH) drew the most net new fund positions in Q2 2026: 531 funds opened new positions, taking total fund holders up 348 (11%) quarter-over-quarter.
- Combined market cap: $10T across 1,123 stocks.
- Largest constituent: Eli Lilly (LLY), $1.26T market cap.
- Most net new fund positions in Q2 2026: UnitedHealth (UNH), +348 holders.
Market caps and prices updated daily; fund activity based on aggregated SEC 13F filings for Q2 2026.